Skip to content

Envoy Medical COCH Proceeds From Warrant Exercises

Proceeds From Warrant Exercises at other companies

BillionToOne, Inc.
 logo
BillionToOne, Inc. BLLN
$6.25K
Upexi logo
UpexiUPXI
$92.11K
Richtech Robotics Inc. logo
Richtech Robotics Inc.RR
$9.18M+126%
NextNav logo
NextNavNN
$13K-97.5%
Airship AI Holdings, Inc. logo
Airship AI Holdings, Inc.AISP
$10-100.0%
OS Therapies logo
OS TherapiesOSTX
$722.22K

Other financials

Income statement

See full
Revenue$39.0K-15.2%
Gross profit-$274.0K-52.2%
Operating income-$6.0M-16.7%
Net income-$4.4M+12.9%
EPS (diluted)-$0.08+72.4%

Balance sheet

See full
Cash & equivalents$25.3M+376%
Total debt$919.0K-2.8%
Total equity$10.2M+142%
Total assets$29.8M+187%

Cash flow

See full
Operating cash flow-$6.1M-62.7%
CapEx$172.0K
Free cash flow-$5.9M-28.5%

Valuation

See full
Market cap$61M+83.5%
P/S260.7×+111×

Profitability

See full
Gross margin-310.7%+31.6pp
Operating margin-9,881.2%+805pp
Net margin-9,875.6%+771pp
FCF margin-7,626.6%-652pp

Returns & leverage

See full
Return on equity328.7%
Debt / equity0.1×
Current ratio2.3×+1.2×

Where this comes from

Reported directly by Envoy Medical in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromWarrantExercises.

The official record: Envoy Medical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Envoy Medical's proceeds from warrant exercises.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Envoy Medical's proceeds from warrant exercises?
Envoy Medical (COCH) reported proceeds from warrant exercises of $2.95M in Q4 2025.
What does proceeds from warrant exercises mean?
Cash inflows resulting from the exercise of outstanding warrants by holders to purchase company equity. This metric indicates the conversion of potential dilution into actual capital and reflects investor confidence in the company's long-term value. It serves as a non-dilutive or secondary source of equity financing.